MAGNAFOLATE-C Trademark

Trademark Overview


On Monday, April 7, 2014, a trademark application was filed for MAGNAFOLATE-C with the United States Patent and Trademark Office. The USPTO has given the MAGNAFOLATE-C trademark a serial number of 86245232. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Monday, October 30, 2023. This trademark is owned by Lianyungang Jinkang Pharmaceutical Technology Co. Ltd. The MAGNAFOLATE-C trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Medicines for human purposes, namely, L-5- methyl tetrahydrofolate for use as a contraceptive; pharmaceutical preparations for the treatment and prevention of diseases and disorders of the respiratory system, gastrointestinal system, endocrine system, cardiovascular system, nervous system, masculoskeletal system, urinary system, integumentary system and reproductive system; pharmaceutical preparations for treatment of blood disease and disorder; dermatologic pharmaceutical preparations; hormone therapy preparations; pharmaceutical preparations for the treatments of colds, coughs and influenza; pharmaceutical preparations for ophthalmic use; pharmaceutical preparations for treating dandruff, laxatives, analgesics, contraceptives, antiseptics; pharmaceutical preparations for treatment of hypertension; pharmaceutical preparations for treatment of obesity; anti allergic pharmaceutical preparations; pharmaceutical preparations for treatment of gout; anti-inflammatory pharmaceuticals; contra...

Industrial chemicals; chemical preparations for scientific purposes, other than for medical or veterinary use; calcium salts; chemical preparations and raw materials in the nature of L-5- methyl tetrahydrofolate for use in the manufacture pharmaceutical, medical and nutritional products; chemicals for use in industry and science; chemicals for use in the pharmaceutical, nutritional and dietary industries
magnafolate-c

General Information


Serial Number86245232
Word MarkMAGNAFOLATE-C
Filing DateMonday, April 7, 2014
Status701 - SECTION 8 - ACCEPTED
Status DateMonday, October 30, 2023
Registration Number5266274
Registration DateTuesday, August 15, 2017
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 28, 2017

Trademark Statements


Description of MarkThe mark consists of the stylized wording "MAGNAFOLATE-C".
Goods and ServicesMedicines for human purposes, namely, L-5- methyl tetrahydrofolate for use as a contraceptive; pharmaceutical preparations for the treatment and prevention of diseases and disorders of the respiratory system, gastrointestinal system, endocrine system, cardiovascular system, nervous system, masculoskeletal system, urinary system, integumentary system and reproductive system; pharmaceutical preparations for treatment of blood disease and disorder; dermatologic pharmaceutical preparations; hormone therapy preparations; pharmaceutical preparations for the treatments of colds, coughs and influenza; pharmaceutical preparations for ophthalmic use; pharmaceutical preparations for treating dandruff, laxatives, analgesics, contraceptives, antiseptics; pharmaceutical preparations for treatment of hypertension; pharmaceutical preparations for treatment of obesity; anti allergic pharmaceutical preparations; pharmaceutical preparations for treatment of gout; anti-inflammatory pharmaceuticals; contraceptive preparations; dietetic foods, namely, folic acid for the treatment of vitamin deficiency; dietetic substances adapted for medical use, namely, folic acid for the treatment of vitamin deficiency; food for babies; nutritional supplements; dietary supplement for animals; antibiotics; vitamin preparations; drugs for medical purposes for the treatment of subacute encephali associated with dementia and vacuolar myelopathy, physiological and pathological vascular and cardiovascular disorders such as premature occlusive arterial diseases, severe vascular diseases in infancy and childhood, progressive arterial stenosis, intermittent claudication, renal vascular hypertension, ischemic cerebrovascular diseases, premature occlusive retinal artery and retinal vein, crebral occlusive arterial diseases, occlusive peripheral arterial diseases, and premature death caused by thromboembolic diseases and/or ischemic heart diseases, autoimmune diseases such as psoriasis, celiac disease, arthritis and inflammatory conditions, megaloblastic anemia caused by folate inficiency, intestinal malabsorption, used as antidote for folic acid antagonists, used for preventing serious toxic effects caused by methotrexate overdose or high-dose therapy, reducing risks of woman miscarriage and/or production of fetuses with neural tube defects, cleft lip and/or palate defects, keeping and/or normalizing homocysteine levels and/or metabolism, changes synthesis of and/or functions and/or variations in dna and rna and changes in synthesis of cells and depression
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesIndustrial chemicals; chemical preparations for scientific purposes, other than for medical or veterinary use; calcium salts; chemical preparations and raw materials in the nature of L-5- methyl tetrahydrofolate for use in the manufacture pharmaceutical, medical and nutritional products; chemicals for use in industry and science; chemicals for use in the pharmaceutical, nutritional and dietary industries

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, April 21, 2014
Primary Code001
First Use Anywhere DateSunday, February 1, 2015
First Use In Commerce DateSunday, February 1, 2015

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 21, 2014
Primary Code005
First Use Anywhere DateSunday, February 1, 2015
First Use In Commerce DateSunday, February 1, 2015

Trademark Owner History


Party NameLianyungang Jinkang Pharmaceutical Technology Co. Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressJiangsu Province, 222000
CN

Party NameLianyungang Jinkang Pharmaceutical Technology Co. Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressJiangsu Province,
CN

Party NameLianyungang Jinkang Pharmaceutical Technology Co. Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJiangsu Province,
CN

Trademark Events


Event DateEvent Description
Monday, October 30, 2023NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Monday, October 30, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, October 30, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, June 27, 2023TEAS SECTION 8 RECEIVED
Monday, August 15, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 15, 2017REGISTERED-PRINCIPAL REGISTER
Friday, July 14, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, July 13, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, July 6, 2017STATEMENT OF USE PROCESSING COMPLETE
Friday, June 9, 2017USE AMENDMENT FILED
Wednesday, July 5, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 9, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, May 23, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 22, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 8, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 18, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 29, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 29, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 29, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 19, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 19, 2016NON-FINAL ACTION E-MAILED
Thursday, May 19, 2016NON-FINAL ACTION WRITTEN
Wednesday, February 3, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 3, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 28, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 3, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 3, 2015NON-FINAL ACTION E-MAILED
Thursday, September 3, 2015NON-FINAL ACTION WRITTEN
Friday, August 14, 2015PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, August 4, 2015WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, July 21, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 15, 2015ASSIGNED TO LIE
Wednesday, July 1, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 19, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 19, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 19, 2015TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, January 5, 2015NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, January 5, 2015FINAL REFUSAL E-MAILED
Monday, January 5, 2015FINAL REFUSAL WRITTEN
Wednesday, December 10, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 10, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 10, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 16, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 16, 2014NON-FINAL ACTION E-MAILED
Wednesday, July 16, 2014NON-FINAL ACTION WRITTEN
Monday, July 14, 2014ASSIGNED TO EXAMINER
Monday, April 21, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 10, 2014NEW APPLICATION ENTERED